Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data

Por Edelman, Steven V.
Publicado no J Diabetes Sci Technol (2016)

Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring

Por Pettus, Jeremy, Edelman, Steven V.
Publicado no Diabetes Technol Ther (2016)

Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)

Por Pettus, Jeremy, Edelman, Steven V.
Publicado no J Diabetes Sci Technol (2016)

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes

Por Pettus, Jeremy, Edelman, Steven V.
Publicado no J Diabetes Sci Technol (2016)

United States Patient Preference and Usability for the New Disposable Insulin Device Solostar(®) versus Other Disposable Pens

Por Fischer, Jerome S., Edelman, Steven V., Schwartz, Sherwyn L.
Publicado em 2008

Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.

Por Baron, A D, Laakso, M, Brechtel, G, Edelman, S V
Publicado em 1991

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

Por Laakso, M, Edelman, S V, Brechtel, G, Baron, A D
Publicado em 1990

A 16-Week Open-Label, Multicenter Pilot Study Assessing Insulin Pump Therapy in Patients with Type 2 Diabetes Suboptimally Controlled with Multiple Daily Injections

Por Frias, Juan P, Bode, Bruce W, Bailey, Timothy S, Kipnes, Mark S, Brunelle, Rocco, Edelman, Steven V
Publicado em 2011

Significant Insulin Dose Errors May Occur if Blood Glucose Results Are Obtained from Miscoded Meters

Por Raine, Charles H., Schrock, Linda E., Edelman, Steven V., Mudaliar, Sunder Raj D., Zhong, Weiping, Proud, Lois J., Parkes, Joan Lee
Publicado em 2007

Ethnic Differences in Complementary and Alternative Medicine Use among Patients with Diabetes

Por Villa-Caballero, Leonel, Morello, Candis M, Chynoweth, Megan E, Prieto-Rosinol, Ariadna, Polonsky, William H, Palinkas, Lawrence A, Edelman, Steven V
Publicado em 2010

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

Por Ilag, L. L., Deeg, M. A., Costigan, T., Hollander, P., Blevins, T. C., Edelman, S. V., Konrad, R. J., Ortmann, R. A., Pollom, R. K., Huster, W. J., Zielonka, J. S., Prince, M. J.
Publicado no Diabetes Obes Metab (2016)